camostat has been researched along with Arteriosclerosis in 1 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuzuya, F | 1 |
| Kuzuya, M | 1 |
| Yasue, M | 1 |
| Naito, M | 1 |
| Funaki, C | 1 |
| Hayashi, T | 1 |
| Asai, K | 1 |
1 other study available for camostat and Arteriosclerosis
| Article | Year |
|---|---|
Clinical and experimental approaches to the prevention of atherosclerosis by immunological regulations.
Topics: Aged; Animals; Arteriosclerosis; Complement Activation; Complement System Proteins; Dextran Sulfate; | 1990 |